Amplia Therapeutics Limited
ampliatx.com · Other · Other
Amplia Therapeutics Limited is an Australian clinical-stage pharmaceutical company based in Melbourne, Victoria. Founded in 2000 and rebranded in 2018, Amplia focuses on developing small-molecule therapies targeting Focal Adhesion Kinase (FAK) to treat cancer and chronic fibrotic diseases.
Company facts
| Founded | 2016 (10 years) |
| Market standing | Publicly traded (ASX: ATX.AX) |
| Employees | 8 |
| Headquarters | Melbourne, Australia |
| Trusted networks on Proven | 2 investor, bank and government networks offer Amplia Therapeutics Limited to their members |
Company facts from Apollo.io company data. Network, offer and redemption data from the Proven platform. A Proven Score is published once publicly named clients are verified with sources.
Source: Proven platform data, public records and vendor websites. Vendors cannot pay to change a score. Methodology. Updated 2026-10-21.